In general
The following provisions shall not apply with respect to the program under this subsection:
(i)#
Paragraphs (1) and (3)(B) of section 1395w–104(a) of this title (relating to dissemination of general information; availability of information on changes in formulary through the internet).
(ii)#
Subparagraphs (A) and (B) of section 1395w–104(b)(3) of this title (relating to requirements on development and application of formularies; formulary development).
(iii)#
Paragraphs (1)(C) and (2) of section 1395w–104(c) of this title (relating to medication therapy management program).